INNOVATE BIOPHARMACEUTICALS Chief Medical Officer Patrick FACP receives $1.0M in 2019

INNOVATE BIOPHARMACEUTICALS reports 2019 executive compensation

By ExecPay News

Published: January 22, 2020

INNOVATE BIOPHARMACEUTICALS reported fiscal year 2019 executive compensation information on January 22, 2020.
In 2019, four executives at INNOVATE BIOPHARMACEUTICALS received on average a compensation package of $551K, a 17% decrease compared to previous year.
Average pay of disclosed executives at INNOVATE BIOPHARMACEUTICALS
Patrick Griffin, M.D., F.A.C.P, Chief Medical Officer, received $1M in total. 43.33% of FACP's compensation, or $448.4K, was in option awards. FACP also received $75K in bonus, $328.1K in salary, as well as $183.4K in stock awards.
Sandeep Laumas, Chairman, received a compensation package of $475.2K, which decreased by 31% compared to previous year. 57.88% of the compensation package, or $275K, was in salary.
Jay P. Madan, President and Chief Business Officer, earned $385.1K in 2019, a 44% decrease compared to previous year.
Christopher Prior, Chief Executive Officer, received $308.7K in 2019, which decreases by 49% compared to 2018.

Related executives

Sandeep Laumas



Christopher Prior


Chief Executive Officer

Jay Madan


President and Chief Business Officer

Patrick FACP


Chief Medical Officer

You may also like

Source: SEC filing on January 22, 2020.